[HTML][HTML] Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine
…, U Ogbogu, B Taylor, T Stafinski, D Menon, T Caulfield - Cell stem cell, 2008 - cell.com
Despite the immature state of stem cell medicine, patients are seeking and accessing putative
stem cell therapies in an "early market" in which direct-to-consumer advertising via the …
stem cell therapies in an "early market" in which direct-to-consumer advertising via the …
Diagnostic accuracy of level 3 portable sleep tests versus level 1 polysomnography for sleep-disordered breathing: a systematic review and meta-analysis
M El Shayeb, LA Topfer, T Stafinski, L Pawluk… - Cmaj, 2014 - Can Med Assoc
… Tania Stafinski helped conceive the design of the review, extracted the data, and edited
and revised the manuscript. Lawrence Pawluk edited and revised the manuscript. Devidas …
and revised the manuscript. Lawrence Pawluk edited and revised the manuscript. Devidas …
Funding the unfundable: mechanisms for managing uncertainty in decisions on the introduction of new and innovative technologies into healthcare systems
T Stafinski, CJ McCabe, D Menon - Pharmacoeconomics, 2010 - Springer
As tensions between payers, responsible for ensuring prudent and principled use of scarce
resources, and both providers and patients, who legitimately want access to technologies …
resources, and both providers and patients, who legitimately want access to technologies …
The impact of chronic obstructive pulmonary disease on work loss in the United States
DD Sin, T Stafinski, YC Ng, NR Bell… - American journal of …, 2002 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) is a rapidly growing public health problem
in the United States and elsewhere. Although direct costs of COPD are well documented, the …
in the United States and elsewhere. Although direct costs of COPD are well documented, the …
[HTML][HTML] Predicting survival after liver transplantation based on pre-transplant MELD score: a systematic review of the literature
KB Klein, TD Stafinski, D Menon - PloS one, 2013 - journals.plos.org
The model for end-stage liver disease (MELD) score is used to stratify candidates for liver
transplantation based on objective measures of disease severity. MELD has been validated as …
transplantation based on objective measures of disease severity. MELD has been validated as …
Engaging the public in priority‐setting for health technology assessment: findings from a citizens' jury
D Menon, T Stafinski - Health Expectations, 2008 - Wiley Online Library
Objectives To assess the feasibility of using a citizens’ jury to elicit public values on health
technologies and to develop criteria for setting priorities for health technology assessment (…
technologies and to develop criteria for setting priorities for health technology assessment (…
[HTML][HTML] Value-based reimbursement decisions for orphan drugs: a scoping review and decision framework
M Paulden, T Stafinski, D Menon, C McCabe - Pharmacoeconomics, 2015 - Springer
Background The rate of development of new orphan drugs continues to grow. As a result,
reimbursing orphan drugs on an exceptional basis is increasingly difficult to sustain from a …
reimbursing orphan drugs on an exceptional basis is increasingly difficult to sustain from a …
Role of patient and public participation in health technology assessment and coverage decisions
D Menon, T Stafinski - Expert review of pharmacoeconomics & …, 2011 - Taylor & Francis
Health technology assessment (HTA) has become an integral part of decision-making on
the coverage of new health technologies in most health systems in the developed world. In …
the coverage of new health technologies in most health systems in the developed world. In …
[PDF][PDF] Health technology assessment in Canada: 20 years strong?
D Menon, T Stafinski - Value in Health, 2009 - inbit.gr
… Devidas Menon and Tania Stafinski have no conflicts to declare. … 19 Menon D,
Stafinski T. Priority-setting for healthcare: who, how, and is it fair? Health Policy 2007;84:220–33. …
Stafinski T. Priority-setting for healthcare: who, how, and is it fair? Health Policy 2007;84:220–33. …
Access with evidence development schemes: a framework for description and evaluation
… Based upon the schemes identified by Stafinski et al.,[1] we can describe five potential
objectives: evidence development, health impact stipulation, efficiency stipulation, budget impact …
objectives: evidence development, health impact stipulation, efficiency stipulation, budget impact …